期刊文献+

Wingspan支架治疗症状性颅内动脉狭窄术后再狭窄的相关因素分析 被引量:19

Predictors of Wingspan in-stent restenosis for the treatment of symptomatic intracranial arterial stenosis
原文传递
导出
摘要 目的 分析症状性颅内动脉狭窄Wingspan支架置人术后再狭窄的相关因素.方法 在南京卒中注册系统中选取2007年1月至2009年12月间成功置入Wingspan支架的症状性颅内动脉粥样硬化性狭窄患者42例,并进行随访观察和分析.根据影像学随访结果将患者分为无再狭窄组和再狭窄组.再狭窄定义为支架内或支架两侧5 mm范围内狭窄程度>50%或血管直径较支架置人时减少>20%.采用多因素Cox回归分析筛选出支架内再狭窄的独立风险因素.结果 影像学随访中位数时间为7(4~23)个月.42例患者(43个病变)中,有15例(35.7%)患者(16个病变,37.2%)发生再狭窄.多因素Cox回归分析显示糖尿病[风险比(HR)=0.281,95%可信区间(CI)=0.088~0.898,P=0.032]和支架直径(HR=0.213,95%CI=0.049~0.918,P=0.038)与Wingspan支架置入术后再狭窄相关.结论 糖尿病和支架直径是症状性颅内动脉狭窄Wingspan支架置入术后再狭窄的独立风险因素. Objective To analyze the predictors of Wingspan in-stent restenosis(ISR)for the treatment of symptomatic intracranial arterial stenosis.Methods Between January 2007 and November 2009,42 patients with symptomatic intracranial arterial stenosis registered in Nanjing stroke registry program (NSRP)were treated with Wingspan stent system.Clinical and follow-up results were retrospectively analyzed.They were divided into the non-restenosis and restenosis groups according to their follow-up imaging data.ISR was defined as>50% stenosis within 5 mm or adjacent to stent or an absolute luminal loss>20% The analysis of stepwise multivariate Cox regression was performed to evaluate the independent predictive flactors.Results ISR was found in 15 patients(15/42,35.7%) with 16 lesions(16/43,37.2%)at a median follow-up period of 7 months(range:4-23).Diabetes(HR=0.281;95% CI=0.088-0.898;P=0.032)and stent diameter(HR=0.213;95% CI=0.049-0.918;P=0.038)were two independent Dredictors for ISR.Conclusion Diabetes and stent diameter may be two independent predictors for ISR after a treatment of Wingspan system.
出处 《中华医学杂志》 CAS CSCD 北大核心 2011年第19期1303-1307,共5页 National Medical Journal of China
基金 国家自然科学基金(30870847) 南京军区"十一五"重点课题(08Z026)
关键词 颅内动脉 支架成形术 再狭窄 血管造影 Intraeranial artery Stenting Restenosis Angiography
  • 相关文献

参考文献10

  • 1Chimowitz MI,Lynn MJ,Howlett-Smith H,et al.Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.N Engl J Med,2005,352:1305-1316.
  • 2Levy EI,Turk AS,Albuquerque FC,et al.Wingspan in-stent restenosis and thrombosis:incidence,clinical presentation,and management.Neurosurgery,2007,61:644-651.
  • 3Gr(o)schel K,Schnandigel S,Pilgram SM,et al.A systematic review on outcome after stenting for intraeranial atherosclerosis.Stroke,2009,40:e340-347.
  • 4Albuquerque FC,Levy EI,Turk AS,et al.Angiographic patterns of wingspan in-stent restenosis.Neurosurgery,2008,63:23-27.
  • 5Scott NA.Restenosis following implantation of bare metal coronary stents:pathophysiology and pathways involved in the vascular response to injmy.Adv Drug Dehv Rev,2006,58:358-76.
  • 6Kornowski R,Mintz GS,Kent KM,et al.Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia.A serial intmvascular ultrasound study.Circulation,1997,95:1366-1369.
  • 7朱双根,朱幼玲,周志明,刘文华,殷勤,马敏敏,樊小兵,徐格林,刘新峰.病变长度对颅内动脉支架成形术后再狭窄的影响[J].中华医学杂志,2010,90(29):2040-2043. 被引量:4
  • 8Turk AS,Levy El,Albuquerque FC,et al.Influence of patient age and stenosis location on wingspan in-stent restenosis.Am J Neuroradiol,2008,29:23-27.
  • 9Marks MP,Wojak JC,Al-Ali F,et al.Angioplasty for sympltomatic intraeranial stenosis:clinical outcome.Stroke,2006.37:1016-1020.
  • 10Wojak JC,Dunlap DC,Hargrave KR,et al.Intracranial angioplasty and stening:long-term results from a single center.Am J Neuroradiol.2006;27:1882-1892.

二级参考文献14

  • 1Wong LK.Global burden of intracranial atherosclerosis.Int J Stroke,2006,1:158-159.
  • 2Chimowitz MI,Lynn MJ,Howlett-Smith H,et al.Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.N Engl J Med,2005,352:1305-1316.
  • 3Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (ssylvia):Study results.Stroke,2004,35:1388-1392.
  • 4Ajari AE,Waksman R,Cheneau E,et al.The outcome of percutaneous coronary intervention in patients with in-stent restenosis who failed intracoronary radiation therapy.J Am Coll Cardiol,2003,41:551-556.
  • 5Liu X,Xu G,Wu W,et al.Subtypes and one-year survival of first-ever stroke in chinese patients:the nanjing stroke registry.Cerebrovasc Dis,2006,22:130-136.
  • 6Levy EI,Turk AS,Albuquerque FC,et al.Wingspan in-stent restenosis and thrombosis:incidence,clinical presentation,and management.Neurosurgery,2007,61:644-650.
  • 7Mazighi M,Yadav JS,Abou-Chebl A.Durability of endovascular therapy for symptomatic intracranial atherosclerosis.Stroke,2008,39:1766-1769.
  • 8Mauri L,O'Malley AJ,Cutlip DE,et al.Effects of stent length and lesion length on coronary restenosis.Am J Cardiol,2004,93:1340-1346.
  • 9Miao ZR,Feng L,Li S,et al.Treatment of symptomatic middle cerebral artery stenosis with balloon-mounted stents:long-term follow-up at a single center.Neurosurgery,2009,64:79-84.
  • 10Kastrati A,Elezi S,Dirschinger J,et al.Influence of lesion length on restenosis after coronary stent placement.Am J Cardiol,1999,83:1617-1622.

共引文献3

同被引文献202

引证文献19

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部